Table 3. Medical therapy and surgical intervention.

Patient	Eye affected	Systemic antifungal therapy and duration	Intravitreal antifungal therapy	No. of intravitreal injections		Surgical intervention	Oral steroids	Intravitreal steroids
				RE	LE
1	LE	Fluconazole, 3wk	Voriconazole (100 µg/0.1 mL)		1	Lensectomy, vitrectomy with secondary IOL implantation	-	-
2	RE	Fluconazole, 2wk	Voriconazole (100 µg/0.1 mL)	1		Diagnostic vitrectomy initially, later combined phacoemulsification, IOL implantation, gas tamponde with endolaser and subsequently vitrectomy with silicone oil tamponade	-	-
3	Both	Voriconazole, 48wk	Voriconazole (50 µg/0.1 mL)	3	1	Vitrectomy in each eye	+48wk	-
4	Both	Fluconazole, 22wk	Voriconazole (100 µg/0.1 mL)	4	4	Vitrectomy in each eye	+36wk	+one injection of dexamethasone (0.4 mg/0.1 mL) in each eye
5	LE	Voriconazole, 40wk	Voriconazole (50 µg/0.1 mL)		8	Vitrectomy twice at 16 week-interval because of non-clearing vitritis	+40wk	+one injection of dexamethasone (0.4 mg/0.1 mL)
6	RE	Fluconazole, 6wk	Voriconazole (100 µg/0.1 mL)	1		Vitrectomy	-	-
7	RE	Fluconazole, 2wk	Did not receive	0		Vitrectomy	-	-
8	Both	Fluconazole, 8wk	Amphotericin (5 µg/0.1 mL)	1	1	RE lensectomy and vitrectomy, no surgical intervention in LE	-	-
9	Both	Fluconazole, 6wk	Amphotericin (5 µg/0.1 mL)	1	0	RE vitrectomy, no surgical intervention in LE	-	-
10	Both	Fluconazole, 6wk initially and for 5 additional months on LE recurrence	LE amphotericin on recurrence of EFE (5 µg/0.1 mL)	0	1	No surgical intervention in either eye	-	-
11	Both	Fluconazole, 8wk	RE voriconazole, (100 µg/0.1 mL) LE amphotericin (one injection; 5 µg/0.1 mL), then voriconazole (one injection)	3	2	Vitrectomy in each eye	+8wk	-
12	Both	Amphotericin, 8wk	Voriconazole (100 µg/0.1 mL)	2	1	Vitrectomy in each eye	-	-
13	RE	Voriconazole, 5wk	Two injections of amphotericin (10 µg/0.1 mL), later one injection of voriconazole (100 µg/0.1 mL)	3		Vitrectomy	+5wk	-

RE: Right eye; LE: Left eye; IOL: Intraocular lens.